Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin. [electronic resource]
Producer: 20110906Description: 867-72 p. digitalISSN:- 1469-5111
- Aged
- Aged, 80 and over
- Alzheimer Disease -- blood
- Amino Acids -- therapeutic use
- Biomarkers -- blood
- Cognition -- drug effects
- Disability Evaluation
- Dose-Response Relationship, Drug
- Double-Blind Method
- Down-Regulation
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Insulin-Like Growth Factor I -- metabolism
- Male
- Middle Aged
- Neuropsychological Tests
- Nootropic Agents -- therapeutic use
- Placebo Effect
- Severity of Illness Index
- Spain
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- blood
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.